BLUEJET

Blue Jet Healthcare, a small-cap player in the pharmaceuticals and biotechnology sector, This adjustment is primarily attributed to a shift in the technical grade, moving from a mildly bullish to a sideways trend. The company's stock is currently priced at Rs 715.80, with a 52-week high of Rs 1,028.20 and a low of Rs 465.00. Recent trading saw a daily high of Rs 720.35 and a low of Rs 705.95. Over the past year, Blue Jet Healthcare has outperformed the broader market, achieving a return of 36.89% compared to a -1.33% decline in the Sensex. Financially, Blue Jet Healthcare has demonstrated strong performance, with a return on equity (ROE) of 26.94% and a significant growth in net sales at an annual rate of 27.13%. The company has reported positive results for four consecutive quarters, with a net profit after tax of Rs 201.27 crore, reflecting a growth of 159.94%. Despite a recent decrease in institutional investor participation, Blue Jet Healthcare remains a notable entity in its sector, constituting nearly 30% of the industry.